Powell6531 Posted - 1 week ago

$ENOV $FXH $ROIV $TXG

swingingtech Posted - 1 week ago

$FXH $ROIV $TXG $ENOV https://wallstreetwaves.com/analyst-sets-unexpected-12-month-price-target-for-fxh/

d_risk Posted - 2 weeks ago

$ENOV - 10Q - Updated Risk Factors Intangible asset impairment risk clarified, highlighting potential negative impact on operating results if Goodwill value declines. No impairment identified yet, but future risks remain. https://d-risk.ai/ENOV/10-Q/2024-11-06

briefingcom Posted - 2 weeks ago

$ENOV: Enovis Corporation beats by $0.11, reports revs in-line; guides FY24 EPS above consensus, revs in-line https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241106060910ENOV&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

DonCorleone77 Posted - 2 weeks ago

$ENOV Enovis raises FY24 adjusted EPS view to $2.75-$2.80 from $2.62-$2.77 FY24 consensus $2.71. Sees FY24 revenue $2.1B, consensus $2.11B. Sees FY24 adjusted EBITDA $373M-$378M.

DonCorleone77 Posted - 2 weeks ago

$ENOV Enovis reports Q3 adjusted EPS 73c, consensus 62c Reports Q3 revenue $505M, consensus $504.07M. "Our performance this quarter reflects the significant progress of our integration efforts and represents a return to above market growth rates in Recon," said Matt Trerotola, Chief Executive Officer of Enovis. "We are closing in on a strong finish for 2024 that will propel us into 2025 as we shift our focus from integration to growth, fueled by a robust lineup of important new product introductions across all areas of our business."

Estimize Posted - 2 weeks ago

$ENOV reported - EPS and - revenue for Q3. http://www.estimize.com/intro/enov?chart=historical&metric_name=eps&utm_content=ENOV&utm_medium=

JackDarwin Posted - 1 month ago

$ENOV Morning star Formed.

WeeklyTrader Posted - 1 month ago

Stay one step ahead! Grab a PUT on $ENOV at strike 40.0p! RSI: 40.73% 50-day MA: $42.97 200-day MA: $51.41

Crom5775 Posted - 2 months ago

$ENOV looks like a inverted head and shoulders pattern. Only 45 watchers. Possible hidden gym?

Crom5775 Posted - 2 months ago

$ENOV volume has picked up recently. May have finally bottomed.

DonCorleone77 Posted - 2 months ago

$ENOV Enovis to unveil Tarsoplasty Percutaneous Lapidus System at AOFAS Meeting Enovis will unveil its new Tarsoplasty Percutaneous Lapidus System and offer live demonstrations of Better Step, a patient-focused platform, alongside other advanced product offerings at the American Orthopaedic Foot & Ankle Society annual meeting in Vancouver, British Columbia from September 11-14, 2024. At the meeting, Enovis will unveil the Tarsoplasty Percutaneous Lapidus System, an innovative approach to the Lapidus bunionectomy that features next generation instruments and implants for a more guided, reproducible percutaneous procedure-enabling surgeons to reduce operative time and improve recovery outcomes for patients. In addition to the Tarsoplasty System, Enovis will offer live demonstrations of Better Step, a patient-focused platform designed to enhance the patient experience throughout the bunion surgery journey. The app encourages physicians to deliver personalized care through custom videos, educational materials, and recovery protocols tailored to each patient's needs.

Stock_Titan Posted - 3 months ago

$ENOV Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability https://www.stocktitan.net/news/ENOV/enovis-introduces-star-r-ankle-now-with-e-polyethylene-for-unmatched-iaguz58zxxld.html

Estimize Posted - 3 months ago

$ENOV reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $7.81M. Reports FQ2 earnings of 62c E... http://www.estimize.com/enov/fq2-2024?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

Stock_Titan Posted - 3 months ago

$ENOV Enovis Announces Second Quarter 2024 Results https://www.stocktitan.net/news/ENOV/enovis-announces-second-quarter-2024-msaeebl3cbg8.html

Estimize Posted - 3 months ago

$ENOV reports before the open tomorrow, Estimize Consensus +0.03 EPS and +7.02M Revs compared to WS http://www.estimize.com/enov/fq2-2024?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits

NVDAMillionaire Posted - 07/29/24

$ENOV Enovis Corp (NYSE:ENOV) – Transformative Acquisition Drives Strong Start to 2024 http://beyondspx.com/2024/07/29/enovis-corp-nyseenov-transformative-acquisition-drives-strong-start-to-2024/

Stock_Titan Posted - 07/25/24

$ENOV Enovis Announces Time Change for Second Quarter 2024 Results Conference Call https://www.stocktitan.net/news/ENOV/enovis-announces-time-change-for-second-quarter-2024-results-9ue3lf5v2ntw.html

Stock_Titan Posted - 4 months ago

$ENOV Enovis to Host Second Quarter 2024 Results Conference Call on August 7th https://www.stocktitan.net/news/ENOV/enovis-to-host-second-quarter-2024-results-conference-call-on-august-i4unam9nch3z.html

Stock_Titan Posted - 4 months ago

$ENOV Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse® https://www.stocktitan.net/news/ENOV/enovis-releases-alti-vate-reverse-r-glenoid-system-widening-range-of-em8m0vukd1sk.html

Thestocktraderhubzee Posted - 4 months ago

$ENOV Evercore ISI Group Maintains Outperform on Enovis, Lowers Price Target to $62

DonCorleone77 Posted - 5 months ago

$ENOV Enovis initiated with a Neutral at JPMorgan JPMorgan initiated coverage of Enovis with a Neutral rating and $53 price target. The analyst sees potential for Enovis to sustainably grow high-single digits and is impressed with the company's recent execution via tuck-in acquisitions. However, the firm is "somewhat concerned" longer term on the sustainability of Enovis' premium growth as incremental tuck-in acquisitions become less growth accretive as the business scales. Further, there isn't a deep internal pipeline of new innovation, says JPMorgan.

HeyDuggee Posted - 6 months ago

$BMY $BIO $BSX $ENOV

Stocksrunner Posted - 6 months ago

📉💼 Turnaround Alert: $NET $NCLH $ENOV $ALRN show signs of potential reversal after entering oversold territory! Keep an eye on these for a possible comeback! 🔄📈

DonCorleone77 Posted - 6 months ago

$ABT $BDX $ENOV $SYK $TWST Evercore ISI removes several healthcare names from 'Tactical Outperform' list Evercore ISI is removing Abbott (ABT), Becton Dickinson (BDX), Enovis (ENOV), Stryker (SYK), Illumina (ILMN) and Twist Bioscience (TWST) from the firm's "Tactical Outperform" list given that the earnings catalysts have passed. The firm still has Mesa Labs (MLAB), which will be reporting in the next three weeks, on the "Tactical Outperform" list, the analyst noted.

Estimize Posted - 6 months ago

$ENOV misses the Estimize EPS Consensus by 2c and beats the Estimize Revenue Consensus by $3.74M. Reports FQ1 earnings of 50c EPS and $... http://www.estimize.com/enov/fq1-2024?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

DonCorleone77 Posted - 6 months ago

$ENOV Enovis raises FY24 adjusted EPS view to $2.52-$2.67 from $2.50-$2.65 FY24 consensus $2.60. Raises FY24 revenue view to $2.06B-$2.16B from $2.05B-$2.15B, consensus $2.12B. Adjusted EBITDA is forecasted to be $368M-383M as compared with the previous outlook of $365M-380M.

DonCorleone77 Posted - 6 months ago

$ENOV Enovis reports Q1 adjusted EPS 50c, consensus 48c Reports Q1 revenue $516M, consensus $503.89M. "We had a great start to 2024, with both revenues and operating margins exceeding expectations," said Matt Trerotola, CEO of Enovis. "Our acquisition of Lima is a transformative milestone and reinforces our ability to innovate and take incremental market share in the global orthopedic market. The integration is progressing according to plan and we remain in the early stages of a multi-year cadence of new product introductions across Recon and P&R."

Stock_Titan Posted - 6 months ago

$ENOV Enovis Announces First Quarter 2024 Results https://www.stocktitan.net/news/ENOV/enovis-announces-first-quarter-2024-sr34ufn7m5wk.html

Estimize Posted - 6 months ago

$ENOV reports before the open tomorrow, Estimize Consensus +0.04 EPS and +6.91M Revs compared to WS http://www.estimize.com/enov/fq1-2024?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits